TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global and United States Sulphonamides Market Report & Forecast 2022-2028

Global and United States Sulphonamides Market Report & Forecast 2022-2028

  • Category:Life Sciences
  • Published on : 14 September 2022
  • Pages :106
  • Formats:
  • Report Code:SMR-7352394
OfferClick for best price

Best Price: $3480

Sulphonamides Market Size, Share 2022


Market Analysis and Insights: Global Sulphonamides Market

The global Sulphonamides market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Sulphonamides market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Sulphonamides market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Sulphonamides market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Sulphonamides market.

Global Sulphonamides Scope and Market Size

Sulphonamides market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Sulphonamides market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Sulphonamides market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type

Orally Absorbable Sulfonamide

Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)

Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide)

Segment by Application

Skin Infections

Gastro Intestinal Tract (GIT) Infection

Meningitis

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

By Company

Abbott Laboratories

Boehringer Ingelheim Pharmaceuticals

Bayer AG

GlaxoSmithKline

King Pharmaceuticals

Mylan Pharmaceuticals

Novartis International AG

Pfizer

Par Pharmaceutical

Roche Holding AG

Sanofi Aventis

Stiefel Laboratories

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Sulphonamides product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Sulphonamides, with price, sales, revenue, and global market share of Sulphonamides from 2019 to 2022.

Chapter 3, the Sulphonamides competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Sulphonamides breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Sulphonamides market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Sulphonamides.

Chapter 13, 14, and 15, to describe Sulphonamides sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Sulphonamides Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global and United States Sulphonamides Market Report & Forecast 2022-2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 106 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Study Coverage
1.1 Sulphonamides Product Introduction
1.2 Global Sulphonamides Outlook 2017 VS 2022 VS 2028
1.2.1 Global Sulphonamides Sales in US$ Million for the Year 2017-2028
1.2.2 Global Sulphonamides Sales in Volume for the Year 2017-2028
1.3 United States Sulphonamides Outlook 2017 VS 2022 VS 2028
1.3.1 United States Sulphonamides Sales in US$ Million for the Year 2017-2028
1.3.2 United States Sulphonamides Sales in Volume for the Year 2017-2028
1.4 Sulphonamides Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Sulphonamides in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Sulphonamides Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Sulphonamides Market Dynamics
1.5.1 Sulphonamides Industry Trends
1.5.2 Sulphonamides Market Drivers
1.5.3 Sulphonamides Market Challenges
1.5.4 Sulphonamides Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Sulphonamides Market Segment by Type
2.1.1 Orally Absorbable Sulfonamide
2.1.2 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
2.1.3 Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide)
2.2 Global Sulphonamides Market Size by Type
2.2.1 Global Sulphonamides Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Sulphonamides Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Sulphonamides Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Sulphonamides Market Size by Type
2.3.1 United States Sulphonamides Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Sulphonamides Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Sulphonamides Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Sulphonamides Market Segment by Application
3.1.1 Skin Infections
3.1.2 Gastro Intestinal Tract (GIT) Infection
3.1.3 Meningitis
3.2 Global Sulphonamides Market Size by Application
3.2.1 Global Sulphonamides Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Sulphonamides Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Sulphonamides Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Sulphonamides Market Size by Application
3.3.1 United States Sulphonamides Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Sulphonamides Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Sulphonamides Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Sulphonamides Competitor Landscape by Company
4.1 Global Sulphonamides Market Size by Company
4.1.1 Top Global Sulphonamides Manufacturers Ranked by Revenue (2021)
4.1.2 Global Sulphonamides Revenue by Manufacturer (2017-2022)
4.1.3 Global Sulphonamides Sales by Manufacturer (2017-2022)
4.1.4 Global Sulphonamides Price by Manufacturer (2017-2022)
4.2 Global Sulphonamides Concentration Ratio (CR)
4.2.1 Sulphonamides Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Sulphonamides in 2021
4.2.3 Global Sulphonamides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Sulphonamides Manufacturing Base Distribution, Product Type
4.3.1 Global Sulphonamides Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Sulphonamides Product Type
4.3.3 Date of International Manufacturers Enter into Sulphonamides Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Sulphonamides Market Size by Company
4.5.1 Top Sulphonamides Players in United States, Ranked by Revenue (2021)
4.5.2 United States Sulphonamides Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Sulphonamides Sales by Players (2020, 2021 & 2022)
5 Global Sulphonamides Market Size by Region
5.1 Global Sulphonamides Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Sulphonamides Market Size in Volume by Region (2017-2028)
5.2.1 Global Sulphonamides Sales in Volume by Region: 2017-2022
5.2.2 Global Sulphonamides Sales in Volume Forecast by Region (2023-2028)
5.3 Global Sulphonamides Market Size in Value by Region (2017-2028)
5.3.1 Global Sulphonamides Sales in Value by Region: 2017-2022
5.3.2 Global Sulphonamides Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Sulphonamides Market Size YoY Growth 2017-2028
6.1.2 North America Sulphonamides Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Sulphonamides Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Sulphonamides Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Sulphonamides Market Size YoY Growth 2017-2028
6.3.2 Europe Sulphonamides Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Sulphonamides Market Size YoY Growth 2017-2028
6.4.2 Latin America Sulphonamides Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Sulphonamides Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Sulphonamides Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Corporation Information
7.1.2 Abbott Laboratories Description and Business Overview
7.1.3 Abbott Laboratories Sulphonamides Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Abbott Laboratories Sulphonamides Products Offered
7.1.5 Abbott Laboratories Recent Development
7.2 Boehringer Ingelheim Pharmaceuticals
7.2.1 Boehringer Ingelheim Pharmaceuticals Corporation Information
7.2.2 Boehringer Ingelheim Pharmaceuticals Description and Business Overview
7.2.3 Boehringer Ingelheim Pharmaceuticals Sulphonamides Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Boehringer Ingelheim Pharmaceuticals Sulphonamides Products Offered
7.2.5 Boehringer Ingelheim Pharmaceuticals Recent Development
7.3 Bayer AG
7.3.1 Bayer AG Corporation Information
7.3.2 Bayer AG Description and Business Overview
7.3.3 Bayer AG Sulphonamides Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Bayer AG Sulphonamides Products Offered
7.3.5 Bayer AG Recent Development
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Corporation Information
7.4.2 GlaxoSmithKline Description and Business Overview
7.4.3 GlaxoSmithKline Sulphonamides Sales, Revenue and Gross Margin (2017-2022)
7.4.4 GlaxoSmithKline Sulphonamides Products Offered
7.4.5 GlaxoSmithKline Recent Development
7.5 King Pharmaceuticals
7.5.1 King Pharmaceuticals Corporation Information
7.5.2 King Pharmaceuticals Description and Business Overview
7.5.3 King Pharmaceuticals Sulphonamides Sales, Revenue and Gross Margin (2017-2022)
7.5.4 King Pharmaceuticals Sulphonamides Products Offered
7.5.5 King Pharmaceuticals Recent Development
7.6 Mylan Pharmaceuticals
7.6.1 Mylan Pharmaceuticals Corporation Information
7.6.2 Mylan Pharmaceuticals Description and Business Overview
7.6.3 Mylan Pharmaceuticals Sulphonamides Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Mylan Pharmaceuticals Sulphonamides Products Offered
7.6.5 Mylan Pharmaceuticals Recent Development
7.7 Novartis International AG
7.7.1 Novartis International AG Corporation Information
7.7.2 Novartis International AG Description and Business Overview
7.7.3 Novartis International AG Sulphonamides Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Novartis International AG Sulphonamides Products Offered
7.7.5 Novartis International AG Recent Development
7.8 Pfizer
7.8.1 Pfizer Corporation Information
7.8.2 Pfizer Description and Business Overview
7.8.3 Pfizer Sulphonamides Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Pfizer Sulphonamides Products Offered
7.8.5 Pfizer Recent Development
7.9 Par Pharmaceutical
7.9.1 Par Pharmaceutical Corporation Information
7.9.2 Par Pharmaceutical Description and Business Overview
7.9.3 Par Pharmaceutical Sulphonamides Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Par Pharmaceutical Sulphonamides Products Offered
7.9.5 Par Pharmaceutical Recent Development
7.10 Roche Holding AG
7.10.1 Roche Holding AG Corporation Information
7.10.2 Roche Holding AG Description and Business Overview
7.10.3 Roche Holding AG Sulphonamides Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Roche Holding AG Sulphonamides Products Offered
7.10.5 Roche Holding AG Recent Development
7.11 Sanofi Aventis
7.11.1 Sanofi Aventis Corporation Information
7.11.2 Sanofi Aventis Description and Business Overview
7.11.3 Sanofi Aventis Sulphonamides Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Sanofi Aventis Sulphonamides Products Offered
7.11.5 Sanofi Aventis Recent Development
7.12 Stiefel Laboratories
7.12.1 Stiefel Laboratories Corporation Information
7.12.2 Stiefel Laboratories Description and Business Overview
7.12.3 Stiefel Laboratories Sulphonamides Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Stiefel Laboratories Products Offered
7.12.5 Stiefel Laboratories Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Sulphonamides Industry Chain Analysis
8.2 Sulphonamides Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Sulphonamides Distributors
8.3 Sulphonamides Production Mode & Process
8.4 Sulphonamides Sales and Marketing
8.4.1 Sulphonamides Sales Channels
8.4.2 Sulphonamides Distributors
8.5 Sulphonamides Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Sulphonamides CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Sulphonamides Market Trends
Table 3. Sulphonamides Market Drivers
Table 4. Sulphonamides Market Challenges
Table 5. Sulphonamides Market Restraints
Table 6. Global Sulphonamides Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Sulphonamides Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Sulphonamides Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Sulphonamides Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Sulphonamides Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Sulphonamides Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Sulphonamides Revenue Share by Manufacturer, 2017-2022
Table 13. Global Sulphonamides Sales by Manufacturer, (K MT), 2017-2022
Table 14. Global Sulphonamides Sales Share by Manufacturer, 2017-2022
Table 15. Global Sulphonamides Price by Manufacturer (2017-2022) & (USD/MT)
Table 16. Global Sulphonamides Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Sulphonamides by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sulphonamides as of 2021)
Table 18. Top Players of Sulphonamides in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Sulphonamides Product Type
Table 20. Date of International Manufacturers Enter into Sulphonamides Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Sulphonamides Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Sulphonamides Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Sulphonamides Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Sulphonamides Sales by Players, (K MT), 2020, 2021 & 2022
Table 26. United States Sulphonamides Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Sulphonamides Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Sulphonamides Sales in Volume by Region (2017-2022) & (K MT)
Table 29. Global Sulphonamides Sales in Volume Forecast by Region (2023-2028) & (K MT)
Table 30. Global Sulphonamides Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Sulphonamides Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Sulphonamides Sales in Volume by Country (2017-2028) & (K MT)
Table 33. North America Sulphonamides Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Sulphonamides Sales in Volume by Region (2017-2028) & (K MT)
Table 35. Asia Pacific Sulphonamides Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Sulphonamides Sales in Volume by Country (2017-2028) & (K MT)
Table 37. Europe Sulphonamides Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Sulphonamides Sales in Volume by Country (2017-2028) & (K MT)
Table 39. Latin Americaa Sulphonamides Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Sulphonamides Sales in Volume by Country (2017-2028) & (K MT)
Table 41. Middle East and Africa Sulphonamides Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Abbott Laboratories Corporation Information
Table 43. Abbott Laboratories Description and Business Overview
Table 44. Abbott Laboratories Sulphonamides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 45. Abbott Laboratories Sulphonamides Product
Table 46. Abbott Laboratories Recent Development
Table 47. Boehringer Ingelheim Pharmaceuticals Corporation Information
Table 48. Boehringer Ingelheim Pharmaceuticals Description and Business Overview
Table 49. Boehringer Ingelheim Pharmaceuticals Sulphonamides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 50. Boehringer Ingelheim Pharmaceuticals Product
Table 51. Boehringer Ingelheim Pharmaceuticals Recent Development
Table 52. Bayer AG Corporation Information
Table 53. Bayer AG Description and Business Overview
Table 54. Bayer AG Sulphonamides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 55. Bayer AG Product
Table 56. Bayer AG Recent Development
Table 57. GlaxoSmithKline Corporation Information
Table 58. GlaxoSmithKline Description and Business Overview
Table 59. GlaxoSmithKline Sulphonamides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 60. GlaxoSmithKline Product
Table 61. GlaxoSmithKline Recent Development
Table 62. King Pharmaceuticals Corporation Information
Table 63. King Pharmaceuticals Description and Business Overview
Table 64. King Pharmaceuticals Sulphonamides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 65. King Pharmaceuticals Product
Table 66. King Pharmaceuticals Recent Development
Table 67. Mylan Pharmaceuticals Corporation Information
Table 68. Mylan Pharmaceuticals Description and Business Overview
Table 69. Mylan Pharmaceuticals Sulphonamides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 70. Mylan Pharmaceuticals Product
Table 71. Mylan Pharmaceuticals Recent Development
Table 72. Novartis International AG Corporation Information
Table 73. Novartis International AG Description and Business Overview
Table 74. Novartis International AG Sulphonamides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 75. Novartis International AG Product
Table 76. Novartis International AG Recent Development
Table 77. Pfizer Corporation Information
Table 78. Pfizer Description and Business Overview
Table 79. Pfizer Sulphonamides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 80. Pfizer Product
Table 81. Pfizer Recent Development
Table 82. Par Pharmaceutical Corporation Information
Table 83. Par Pharmaceutical Description and Business Overview
Table 84. Par Pharmaceutical Sulphonamides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 85. Par Pharmaceutical Product
Table 86. Par Pharmaceutical Recent Development
Table 87. Roche Holding AG Corporation Information
Table 88. Roche Holding AG Description and Business Overview
Table 89. Roche Holding AG Sulphonamides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 90. Roche Holding AG Product
Table 91. Roche Holding AG Recent Development
Table 92. Sanofi Aventis Corporation Information
Table 93. Sanofi Aventis Description and Business Overview
Table 94. Sanofi Aventis Sulphonamides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 95. Sanofi Aventis Product
Table 96. Sanofi Aventis Recent Development
Table 97. Stiefel Laboratories Corporation Information
Table 98. Stiefel Laboratories Description and Business Overview
Table 99. Stiefel Laboratories Sulphonamides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 100. Stiefel Laboratories Product
Table 101. Stiefel Laboratories Recent Development
Table 102. Key Raw Materials Lists
Table 103. Raw Materials Key Suppliers Lists
Table 104. Sulphonamides Customers List
Table 105. Sulphonamides Distributors List
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Sulphonamides Product Picture
Figure 2. Global Sulphonamides Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Sulphonamides Market Size 2017-2028 (US$ Million)
Figure 4. Global Sulphonamides Sales 2017-2028 (K MT)
Figure 5. United States Sulphonamides Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Sulphonamides Market Size 2017-2028 (US$ Million)
Figure 7. United States Sulphonamides Sales 2017-2028 (K MT)
Figure 8. United States Sulphonamides Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Sulphonamides Market Share in Global, in Volume (K MT) 2017-2028
Figure 10. Sulphonamides Report Years Considered
Figure 11. Product Picture of Orally Absorbable Sulfonamide
Figure 12. Product Picture of Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
Figure 13. Product Picture of Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide)
Figure 14. Global Sulphonamides Market Share by Type in 2022 & 2028
Figure 15. Global Sulphonamides Sales in Value by Type (2017-2028) & (US$ Million)
Figure 16. Global Sulphonamides Sales Market Share in Value by Type (2017-2028)
Figure 17. Global Sulphonamides Sales by Type (2017-2028) & (K MT)
Figure 18. Global Sulphonamides Sales Market Share in Volume by Type (2017-2028)
Figure 19. Global Sulphonamides Price by Type (2017-2028) & (USD/MT)
Figure 20. United States Sulphonamides Market Share by Type in 2022 & 2028
Figure 21. United States Sulphonamides Sales in Value by Type (2017-2028) & (US$ Million)
Figure 22. United States Sulphonamides Sales Market Share in Value by Type (2017-2028)
Figure 23. United States Sulphonamides Sales by Type (2017-2028) & (K MT)
Figure 24. United States Sulphonamides Sales Market Share in Volume by Type (2017-2028)
Figure 25. United States Sulphonamides Price by Type (2017-2028) & (USD/MT)
Figure 26. Product Picture of Skin Infections
Figure 27. Product Picture of Gastro Intestinal Tract (GIT) Infection
Figure 28. Product Picture of Meningitis
Figure 29. Global Sulphonamides Market Share by Application in 2022 & 2028
Figure 30. Global Sulphonamides Sales in Value by Application (2017-2028) & (US$ Million)
Figure 31. Global Sulphonamides Sales Market Share in Value by Application (2017-2028)
Figure 32. Global Sulphonamides Sales by Application (2017-2028) & (K MT)
Figure 33. Global Sulphonamides Sales Market Share in Volume by Application (2017-2028)
Figure 34. Global Sulphonamides Price by Application (2017-2028) & (USD/MT)
Figure 35. United States Sulphonamides Market Share by Application in 2022 & 2028
Figure 36. United States Sulphonamides Sales in Value by Application (2017-2028) & (US$ Million)
Figure 37. United States Sulphonamides Sales Market Share in Value by Application (2017-2028)
Figure 38. United States Sulphonamides Sales by Application (2017-2028) & (K MT)
Figure 39. United States Sulphonamides Sales Market Share in Volume by Application (2017-2028)
Figure 40. United States Sulphonamides Price by Application (2017-2028) & (USD/MT)
Figure 41. North America Sulphonamides Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 42. North America Sulphonamides Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 43. U.S. Sulphonamides Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Canada Sulphonamides Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Europe Sulphonamides Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 46. Europe Sulphonamides Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 47. Germany Sulphonamides Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. France Sulphonamides Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. U.K. Sulphonamides Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Italy Sulphonamides Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Russia Sulphonamides Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Asia-Pacific Sulphonamides Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 53. Asia-Pacific Sulphonamides Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 54. China Sulphonamides Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. Japan Sulphonamides Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. South Korea Sulphonamides Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. India Sulphonamides Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Australia Sulphonamides Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Taiwan Sulphonamides Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Indonesia Sulphonamides Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Thailand Sulphonamides Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Malaysia Sulphonamides Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Philippines Sulphonamides Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Latin America Sulphonamides Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 65. Latin America Sulphonamides Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 66. Mexico Sulphonamides Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Brazil Sulphonamides Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Argentina Sulphonamides Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Middle East & Africa Sulphonamides Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 70. Middle East & Africa Sulphonamides Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 71. Turkey Sulphonamides Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Saudi Arabia Sulphonamides Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. UAE Sulphonamides Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. Sulphonamides Value Chain
Figure 75. Sulphonamides Production Process
Figure 76. Channels of Distribution
Figure 77. Distributors Profiles
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount